Thermo Fisher Scientific

World's largest life science supplier — HyPerforma single-use bioreactors, cell culture media, and biopharma services spanning R&D to commercial manufacturing.

Country: United States
Revenue: $42.9B
Employees: ~120,000 emp

FDA GMP ISO 9001

Coverage

	CN	EU	IN	US
analytics-pat	✓	✓	—	✓
automation-robotics	—	✓	—	✓
bioinformatics-omics	✓	✓	—	✓
cleanroom-facilities	✓	✓	—	✓
consumables	✓	✓	—	✓
genome-engineering	✓	✓	—	✓
marine-biotech	✓	✓	—	✓
market-access-commercial	✓	✓	✓	✓
therapeutics-platforms	✓	✓	—	✓
upstream-bioreactors	✓	✓	—	✓

Regulatorsfdaemanmpa

Verifiable facts

Fact	Value	Source
Revenue	$44.56 billion for 2025	sec.gov
Headcount	more than 120,000 colleagues	sec.gov
Capacity	over 35,000 L of production capacity at the St. Louis, Missouri facility	patheon.com
Certification	Maintains various certified facilities including US-FDA, EU-GMP, Japan-PMDA, and UK certified facilities medium confidence	chemxpert.com
Regulatory approval	FDA approval for Oncomine Dx Express test and 510(k) clearance for EXENT System in 2025	sec.gov
Production site	Includes 64 U.S. manufacturing operations; specific sites include St. Louis, MO; Nashville, TN; Logan, UT; Grand Island, NY; Miami, FL; Bedford, MA; Chelmsford, MA; and international sites in Suzhou, China; Singapore; and India	ir.thermofisher.com · patheon.com
Funding	In 2025, the company deployed approximately $16.5 billion of capital, including committing $13 billion to M&A and $1.4 billion in R&D	sec.gov

Independent sources: chemxpert.com · patheon.com · sec.gov

Technologies

Name	Cluster	Risk
Automated nucleic acid extraction	analytics-pat	Low	→
Bioluminescence & marine fluorescent proteins	marine-biotech	Low	→
Bioprocess analytics & PAT (process analytical technology)	analytics-pat	Low	→
Bioproduction CDMO/CMO (biologics/ATMP/mRNA)	therapeutics-platforms	Low	→
Biosafety & lab biosecurity	genome-engineering	Low	→
Biosafety cabinets and laminar flow hoods	analytics-pat	Low	→
Cell counters and viability systems	analytics-pat	Low	→
Cell culture media (B2B consumable)	cleanroom-facilities	Low	→
Fill-finish & aseptic biomanufacturing	therapeutics-platforms	Low	→
Flow cytometers for bioproduction	analytics-pat	Low	→
Gantry robots for wet labs	automation-robotics	Low	→
HPLC/UPLC instruments for biopharma	analytics-pat	Low	→
Laboratory execution systems (LES)	analytics-pat	Low	→
Local manufacturing for market access	market-access-commercial	Low	→
Mass spectrometers for biopharma characterization	analytics-pat	Low	→
Media manufacturing (B2B production equipment)	cleanroom-facilities	Low	→
Single-use assemblies	consumables	Low	→
Single-use bag bioreactors (50L-2000L)	upstream-bioreactors	Low	→
Single-use bioprocessing & modular factories	upstream-bioreactors	Low	→
Structural biology (cryo-EM CRO)	bioinformatics-omics	Medium	→
Wave bioreactors for seed-train expansion	upstream-bioreactors	Low	→

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.